Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models

Published:2015-12-16 Issue:3 Volume:13 Page:325-336
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Alavizadeh Seyedeh Hoda,Akhtari Javad,Badiee Ali,Golmohammadzadeh Shiva,Jaafari Mahmoud Reza

Funder

Biotechnology Research Center and Nanotechnology Research Center, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran.

Publisher

Informa Healthcare

Subject

Pharmaceutical Science

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425247.2016.1121987

Reference61 articles.

1. From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy

2. Cisplatin Nephrotoxicity: A Review

3. Molecular Determinants of the Cytotoxicity of Platinum Compounds

4. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application

5. Nanocarriers as an emerging platform for cancer therapy

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-based chemotherapy: trends in organic nanodelivery systems;Nanoscale;2024

2. Functionalized liposomes for targeted breast cancer drug delivery;Bioactive Materials;2023-06

3. Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors;Molecular Pharmaceutics;2023-05-03

4. Challenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum;Chemistry and Physics of Lipids;2023-01

5. Amino acid coordination complex mediates cisplatin entrapment within PEGylated liposome: An implication in colorectal cancer therapy;International Journal of Pharmaceutics;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3